Nebraska Medicine achieves Stage 7 on EMRAM scale

Beth Walsh | | Health Exec | EMR/EHR

Nebraska Medicine, comprising the University of Nebraska Medical Center, Bellevue Medical Center and UNMC Physicians, is the latest provider recognized for achieving Stage 7 on HIMSS Analytics' Electronic Medical Record Adoption Model.

Only 4.1 percent of the 5,400 U.S. hospitals in the HIMSS Analytics Database achieve the award for EMR adoption.

"We are delighted to achieve this milestone, showcasing our dedication to quality and patient care," said Nebraska Medicine Interim CEO Rosanna Morris in a statement. "Nebraska Medicine continues to dedicate time, talent and resources to the development and integration of our electronic medical record, in order to provide the highest quality of care to our patients."

Nebraska Medicine employs more than 1,000 physicians in the Omaha region and serves more than 500,000 patients annually. The IT department is led by Chief Transformation Officer Michael Ash, MD.

The health system uses a single, integrated Epic EMR, the result of an $87 million investment in 2012. Nebraska Medicine continues to add to the system, including a 2013 introduction of One Chart, an EHR system designed to boost communication between patients and providers.

"Nebraska Medicine has effectively developed its governance, clinical and business analytics and disaster recovery/business continuity strategies in a way that helps to ensure process improvements are sustainable," said John H. Daniels, global vice president, healthcare advisory services group, HIMSS Analytics.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup